Clinical Trial Update: Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant chemotherapy plus Herceptin in HER2-positive stage II-III breast cancer has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Accelerated Community Oncology Research Network | Conditions: Breast Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2012-03-12